[صفحه اصلی ]   [Archive]  
:: صفحه اصلي درباره نشريه آخرين شماره تمام شماره‌ها جستجو ثبت نام ارسال مقاله تماس با ما ::
بخش‌های اصلی
صفحه اصلی::
اطلاعات نشریه::
آرشیو مجله و مقالات::
برای نویسندگان::
برای داوران::
ثبت نام و اشتراک::
تماس با ما::
تسهیلات پایگاه::
بایگانی مقالات زیر چاپ::
::
جستجو در پایگاه

جستجوی پیشرفته
..
دریافت اطلاعات پایگاه
نشانی پست الکترونیک خود را برای دریافت اطلاعات و اخبار پایگاه، در کادر زیر وارد کنید.
..
:: دوره 2، شماره 2 - ( 3-1392 ) ::
جلد 2 شماره 2 صفحات 0-0 برگشت به فهرست نسخه ها
MECHANISMS OF HYPERCOAGULABILITY PROMOTED BY ORAL COMBINED CONTRACEPTIVES
چکیده:   (10858 مشاهده)
Background: Hormonal contraceptive pills are the most used reversible method for familiar planning in Brazil. The combined pill, with synthetic analogs of estrogen and progestin, is employed by 25% of Brazilian female population. Its use provokes an increase of blood pressure levels, takes patient to a hipercoagulability state and predisposes her to thromboembolic events. Purposes: We aimed to describe mechanisms of hypercoagulability promoted by oral combined contraceptives, to analyze the relative risk of cardiovascular events within users and to list the most common circulatory pathologies in these patients. Methods: Three virtual medical databases were surveyed (Pubmed/Medline, BVS/LILACS and Scielo). Twelve studies were selected: clinical trials, case reports and articles of indexed medical periodic originally published in Portuguese and English about synthetic hormones, oral contraception, coagulation disorders and cardiovascular morbimortality. Results: Synthetic estrogen promotes an increase of some clotting factors’ levels (VII, VIII, IX, X, XII, XIII and fibrinogen), such as a reduction of their inhibitors (S protein and antithrombin). Because of this, etinilestradiol is the component most related to venous thrombosis and ischemic diseases of brain and heart. It also improves the releasing of hepatic angiotensinogen, taking to a increase of blood pressure levels. Conclusions: The prescription of oral combined contraceptives needs criteria, notably due to adverse effects of etinilestradiol. It is recommended to avoid the administration of these drugs for patients elder than 35 year-old or with risk factors. For these patients, the use of progestagen-only pills seems to be safer.
     
نوع مطالعه: مروری | موضوع مقاله: عمومى
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gonçalves B B, de Alencar R B, Neto M L R, de Alencar M D F B. MECHANISMS OF HYPERCOAGULABILITY PROMOTED BY ORAL COMBINED CONTRACEPTIVES. Int J Med Invest 2013; 2 (2)
URL: http://intjmi.com/article-1-39-fa.html

MECHANISMS OF HYPERCOAGULABILITY PROMOTED BY ORAL COMBINED CONTRACEPTIVES. . 1392; 2 (2)

URL: http://intjmi.com/article-1-39-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 2، شماره 2 - ( 3-1392 ) برگشت به فهرست نسخه ها
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645